A Pilot Trial of Rituxan in Refractory Myasthenia Gravis

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Dr. Rup Tandan, M.D., F.R.C.P., University of Vermont
ClinicalTrials.gov Identifier:
NCT00619671
First received: January 14, 2008
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)